Houston Natural Resources-Backed Energy SPAC HNR Acquisition Closes US$86.25 Million IPO

Special purpose acquisition company HNR Acquisition Corp. (NYSE: HNRAU) closed its initial public offering on the New York Stock Exchange on Thursday. The firm was able to raise US$86.25 million from its oversubscribed IPO.

The offering originally consisted of 7.5 million units priced at US$10.00 per unit for a total IPO size of US$75 million. The underwriter exercised the over-allotment option to purchase additional 1.125 million units at the same IPO price.

The company units trade on the New York-based big board under the symbol “HNRAU”. Once the securities separate, the company shares and warrants will trade under the ticker symbols “HNRA” and “HNRAW”, respectively.

EF Hutton acted as the sole bookrunner for the offering.

Houston Natural Resources founder and CEO Donald Goree also serves as the SPAC’s chairman and CEO.

According to its filing statement, the blank-check company intends to focus on acquiring a business involved in natural gas, natural gas liquids, crude oil, or refined products in North America.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

SPAC Gardiner Healthcare Acquisitions Prices US$75 Million IPO

Special purpose acquisition company Gardiner Healthcare Acquisitions Corp. (NASDAQ: GDNRU) started trading publicly on the...

Wednesday, December 22, 2021, 04:32:00 PM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

Hemp Manufacturer Hempacco Prices Downsized US$6 Million IPO

Hemp manufacturing company Hempacco Co., Inc. (Nasdaq: HPCO) started trading its shares on the Nasdaq...

Tuesday, August 30, 2022, 02:19:00 PM

Real Estate-Focused Fintech SPAC Southport Acquisition Prices US$200 Million IPO

Special purpose acquisition company Southport Acquisition Corporation (NYSE: PORT.U) went public on Friday at the...

Monday, December 13, 2021, 02:19:00 PM

Financial SPAC Cascade Acquisition Looks At Liquidation After Failing To Achieve Business Combination

Special purpose acquisition company Cascade Acquisition Corp. (NYSE: CAS) announced its intention to dissolve and...

Thursday, May 19, 2022, 02:23:00 PM